Po-Hsiang Huang

A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy.

Chih-Hung Hsu, Y. Chao, A. Cheng, 2020, The oncologist.

Durable control of metastatic nasopharyngeal carcinoma with metronomic chemotherapy

Jo-Pai Chen, Chun-Wei Wang, Po-Hsiang Huang, 2017 .